Vagus Nerve-guided Robotic-assisted Splenectomy and Azygoportal Disconnection
VNRSD
Vagus Nerve-guided Versus Conventional Robotic-assisted Splenectomy and Azygoportal Disconnection
1 other identifier
interventional
60
1 country
1
Brief Summary
This study aimed to evaluate whether vagus nerve-guided robotic-assisted splenectomy and azygoportal disconnection is effective and safe, and to determine whether a reduction in the incidence of postoperative complications of the digestive system improves postoperative quality of life compared with conventional robotic-assisted splenectomy and azygoportal disconnection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2022
CompletedFirst Posted
Study publicly available on registry
March 29, 2022
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedApril 1, 2026
March 1, 2026
1.3 years
March 18, 2022
March 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Diarrhea
Proportions of patients who will suffer from diarrhea in both groups.
3 month
Delayed gastric emptying
Proportions of patients who will suffer from delayed gastric emptying in both groups.
3 month
Secondary Outcomes (2)
Postoperative complications of the digestive system
3 month
Esophagogastric variceal re-bleeding
3 month
Study Arms (2)
vagus nerve-guided group
EXPERIMENTALProcedure/Surgery: vagus nerve-guided group The vagus nerve-guided procedure was performed in the following order: (1) find the left crural diaphragm; (2) via the surface of the left crural diaphragm, blunt dissect the left lateral surface of the distal esophagus using Bipolar Forceps, and find posterior vagal trunk; (3) along posterior vagal trunk towards left lateral esoph-agogastric junction, find and protect gastric and celiac branches; (4) enter the lesser omental sac from the right crural diaphragm using Bipolar Forceps; (5) transect the left gastric artery and vein together using a linear vascular stapler; (6) blunt dissect the anterior surface of the distal esophagus using Bipolar Forceps, and find anterior vagal trunk; (7) along anterior vagal trunk towards right lateral esoph-agogastric junction, find and protect gastric and hepatic branches; and (8) blunt dissect the right lateral surface of the distal esophagus. The hepatogastric ligament was conserved.
Conventional group
NO INTERVENTIONEvery patient of conventional group will receive the conventional Robotic-assisted azygoportal disconnection procedure.
Interventions
The vagus nerve-guided procedure was performed in the following order: (1) find the left crural diaphragm; (2) via the surface of the left crural diaphragm, blunt dissect the left lateral surface of the distal esophagus using Bipolar Forceps, and find posterior vagal trunk; (3) along posterior vagal trunk towards left lateral esoph-agogastric junction, find and protect gastric and celiac branches; (4) enter the lesser omental sac from the right crural diaphragm using Bipolar Forceps; (5) transect the left gastric artery and vein together using a linear vascular stapler; (6) blunt dissect the anterior surface of the distal esophagus using Bipolar Forceps, and find anterior vagal trunk; (7) along anterior vagal trunk towards right lateral esoph-agogastric junction, find and protect gastric and hepatic branches; and (8) blunt dissect the right lateral surface of the distal esophagus. The hepatogastric ligament was conserved.
Eligibility Criteria
You may qualify if:
- A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
- Splenomegaly with secondary hypersplenism
- Bleeding portal hypertension
- No evidence of portal vein system thrombosis by ultrasound evaluation and angio-CT
- Informed consent to participate in the study
You may not qualify if:
- Delayed gastric emptying
- Diarrhea
- Hepatocellular carcinoma or any other malignancy,
- Hypercoagulable state other than the liver disease related
- DRUGS- oral contraceptives, anticoagulation or anti-platelet drugs.
- Child - Pugh C
- Recent peptic ulcer disease
- History of Hemorrhagic stroke
- Pregnancy.
- Uncontrolled Hypertension
- Human immunodeficiency virus (HIV) infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Medical College, Yangzhou University
Yangzhou, Jiangsu, 225001, China
Related Publications (1)
Bai DS, Jin SJ, Zhou BH, Xiang XX, Qian JJ, Zhang C, Gao TM, Jiang GQ. Vagus nerve-guided (modified Bai-Jiang-style) robotic-assisted laparoscopic splenectomy and azygoportal disconnection. Int J Med Robot. 2023 Apr;19(2):e2490. doi: 10.1002/rcs.2490. Epub 2022 Dec 11.
PMID: 36478144DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dou-Sheng Bai, MD
Clinical Medical College, Yangzhou University
- PRINCIPAL INVESTIGATOR
Guo-Qing Jiang, MD
Clinical Medical College, Yangzhou University
- STUDY DIRECTOR
Ping Chen, MD
Clinical Medical College, Yangzhou University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
March 18, 2022
First Posted
March 29, 2022
Study Start
April 1, 2022
Primary Completion
July 31, 2023
Study Completion
July 31, 2023
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share